Center for Clinical Research Inc. (CCR)
Background
Founded in 2003 by Dr. Alexander Reyzelman, the Center for Clinical Research Inc. (CCR) is a Site Management Organization (SMO) headquartered in San Francisco, California. Initially focusing on lower limb wound care, CCR has expanded its expertise to encompass multiple therapeutic areas, including Neurology, Internal Medicine, and Pain Management. The organization collaborates with pharmaceutical companies, medical device manufacturers, biotechnology firms, and contract research organizations to promote the benefits of clinical trials to patients, physicians, and the broader healthcare community.
Key Strategic Focus
CCR's strategic objectives include:
- Multi-Therapeutic Expertise: Offering comprehensive services across various medical fields such as Neurology, Internal Medicine, and Pain Management.
- Clinical Trial Phases: Managing all four phases of clinical trials with a focus on quality and efficiency.
- Collaborative Partnerships: Engaging with a diverse range of stakeholders to enhance clinical research outcomes.
- Patient and Physician Education: Raising awareness about the advantages of clinical trials within the healthcare ecosystem.
Financials and Funding
While specific financial details are not publicly disclosed, CCR's estimated revenue ranges between $1 million and $10 million. The company operates as a privately held entity, and information regarding funding rounds or external investments is not available.
Pipeline Development
CCR's pipeline includes clinical trials across multiple therapeutic areas. The organization manages studies in various phases, from early-stage trials to late-stage evaluations, targeting conditions within Neurology, Internal Medicine, and Pain Management. Specific details about ongoing trials and anticipated milestones are not publicly disclosed.
Technological Platform and Innovation
CCR leverages advanced technologies and methodologies to enhance clinical trial processes, including:
- Electronic Data Capture (EDC): Utilizing digital systems for efficient data collection and management.
- Remote Monitoring: Implementing virtual tools to oversee trial progress and ensure compliance.
- Patient Recruitment Platforms: Employing digital strategies to identify and engage suitable trial participants.
Leadership Team
- Dr. Alexander Reyzelman: Founder and Chief Executive Officer, with extensive experience in clinical research and a background in podiatric medicine.
- Rozana Reyzelman: Clinical Operations Manager, overseeing the execution of clinical trials and operational strategies.
- Maria Peralta: Clinical Research Manager, responsible for managing research activities and ensuring regulatory compliance.
- Gayana Sarkisova: Clinical Site Manager, coordinating site operations and maintaining quality standards.
Leadership Changes
As of the latest available information, there have been no recent significant changes or appointments within CCR's leadership team.
Competitor Profile
Market Insights and Dynamics
The clinical research industry is experiencing significant growth, driven by increasing demand for innovative therapies and the globalization of clinical trials. The global contract research organization (CRO) market is projected to reach $90.93 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 11.4% during the forecast period.
Competitor Analysis
CCR operates in a competitive landscape alongside several notable organizations:
- IQVIA: A leading global provider of advanced analytics, technology solutions, and contract research services, offering comprehensive clinical trial management and real-world insights.
- Parexel International Corporation: Specializes in clinical research, regulatory consulting, and market access solutions, supporting the development and commercialization of new medical treatments.
- Syneos Health: Combines clinical research and commercial services to provide integrated biopharmaceutical solutions, focusing on late-stage clinical trials and commercialization strategies.
- Charles River Laboratories: Offers preclinical and clinical laboratory services, including laboratory animal models, toxicology, and safety assessment, supporting drug development processes.
Strategic Collaborations and Partnerships
CCR collaborates with a wide range of stakeholders, including pharmaceutical companies, medical device manufacturers, biotechnology firms, and contract research organizations. These partnerships aim to enhance clinical trial outcomes and promote the benefits of clinical research to patients and healthcare professionals.
Operational Insights
CCR's strategic considerations include:
- Quality Assurance: Maintaining high standards of patient care and data integrity through dedicated research staff and rigorous protocols.
- Operational Efficiency: Streamlining clinical trial processes to reduce timelines and costs.
- Regulatory Compliance: Ensuring adherence to regulatory requirements across all trial phases.
Strategic Opportunities and Future Directions
CCR is positioned to capitalize on several strategic opportunities:
- Expansion of Therapeutic Areas: Broadening research into additional medical fields to meet evolving healthcare needs.
- Adoption of Decentralized Trials: Implementing virtual and remote trial methodologies to increase patient accessibility and engagement.
- Technological Integration: Enhancing data analytics capabilities to improve trial design and outcomes.
Contact Information
- Website: www.center4clinicalresearch.com
- Headquarters: San Francisco, California, United States
Note: Specific contact details such as email addresses and phone numbers are not provided in this profile.
